Global and United States Hepatitis B Virus (HBV) Market Report & Forecast 2022-2028

SKU ID :QYR-20651471 | Published Date: 01-Apr-2022 | No. of pages: 92
1 Study Coverage 1.1 Hepatitis B Virus (HBV) Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Introduction 1.2 Global Hepatitis B Virus (HBV) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Hepatitis B Virus (HBV) Market Size for the Year 2017-2028 1.2.2 Global Hepatitis B Virus (HBV) Market Size for the Year 2017-2028 1.3 Hepatitis B Virus (HBV) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Hepatitis B Virus (HBV) in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Hepatitis B Virus (HBV) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Hepatitis B Virus (HBV) Market Dynamics 1.4.1 Hepatitis B Virus (HBV) Industry Trends 1.4.2 Hepatitis B Virus (HBV) Market Drivers 1.4.3 Hepatitis B Virus (HBV) Market Challenges 1.4.4 Hepatitis B Virus (HBV) Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Hepatitis B Virus (HBV) by Type 2.1 Hepatitis B Virus (HBV) Market Segment by Type 2.1.1 Therapeutics 2.1.2 Vaccine 2.2 Global Hepatitis B Virus (HBV) Market Size by Type (2017, 2022 & 2028) 2.3 Global Hepatitis B Virus (HBV) Market Size by Type (2017-2028) 2.4 United States Hepatitis B Virus (HBV) Market Size by Type (2017, 2022 & 2028) 2.5 United States Hepatitis B Virus (HBV) Market Size by Type (2017-2028) 3 Hepatitis B Virus (HBV) by Application 3.1 Hepatitis B Virus (HBV) Market Segment by Application 3.1.1 Hospitals 3.1.2 Ambulatory Surgical Centers 3.1.3 Diagnostic Centers 3.2 Global Hepatitis B Virus (HBV) Market Size by Application (2017, 2022 & 2028) 3.3 Global Hepatitis B Virus (HBV) Market Size by Application (2017-2028) 3.4 United States Hepatitis B Virus (HBV) Market Size by Application (2017, 2022 & 2028) 3.5 United States Hepatitis B Virus (HBV) Market Size by Application (2017-2028) 4 Global Hepatitis B Virus (HBV) Competitor Landscape by Company 4.1 Global Hepatitis B Virus (HBV) Market Size by Company 4.1.1 Top Global Hepatitis B Virus (HBV) Companies Ranked by Revenue (2021) 4.1.2 Global Hepatitis B Virus (HBV) Revenue by Player (2017-2022) 4.2 Global Hepatitis B Virus (HBV) Concentration Ratio (CR) 4.2.1 Hepatitis B Virus (HBV) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Hepatitis B Virus (HBV) in 2021 4.2.3 Global Hepatitis B Virus (HBV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Hepatitis B Virus (HBV) Headquarters, Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Type 4.3.1 Global Hepatitis B Virus (HBV) Headquarters and Area Served 4.3.2 Global Hepatitis B Virus (HBV) Companies Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Hepatitis B Virus (HBV) Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Hepatitis B Virus (HBV) Market Size by Company 4.5.1 Top Hepatitis B Virus (HBV) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Hepatitis B Virus (HBV) Revenue by Players (2020, 2021 & 2022) 5 Global Hepatitis B Virus (HBV) Market Size by Region 5.1 Global Hepatitis B Virus (HBV) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Hepatitis B Virus (HBV) Market Size by Region (2017-2028) 5.2.1 Global Hepatitis B Virus (HBV) Market Size by Region: 2017-2022 5.2.2 Global Hepatitis B Virus (HBV) Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Hepatitis B Virus (HBV) Market Size YoY Growth 2017-2028 6.1.2 North America Hepatitis B Virus (HBV) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Hepatitis B Virus (HBV) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Hepatitis B Virus (HBV) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Hepatitis B Virus (HBV) Market Size YoY Growth 2017-2028 6.3.2 Europe Hepatitis B Virus (HBV) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Hepatitis B Virus (HBV) Market Size YoY Growth 2017-2028 6.4.2 Latin America Hepatitis B Virus (HBV) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Hepatitis B Virus (HBV) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Hepatitis B Virus (HBV) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Merck 7.1.1 Merck Company Details 7.1.2 Merck Business Overview 7.1.3 Merck Hepatitis B Virus (HBV) Introduction 7.1.4 Merck Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.1.5 Merck Recent Development 7.2 Gilead Sciences 7.2.1 Gilead Sciences Company Details 7.2.2 Gilead Sciences Business Overview 7.2.3 Gilead Sciences Hepatitis B Virus (HBV) Introduction 7.2.4 Gilead Sciences Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.2.5 Gilead Sciences Recent Development 7.3 Novartis 7.3.1 Novartis Company Details 7.3.2 Novartis Business Overview 7.3.3 Novartis Hepatitis B Virus (HBV) Introduction 7.3.4 Novartis Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.3.5 Novartis Recent Development 7.4 GlaxoSmithKline 7.4.1 GlaxoSmithKline Company Details 7.4.2 GlaxoSmithKline Business Overview 7.4.3 GlaxoSmithKline Hepatitis B Virus (HBV) Introduction 7.4.4 GlaxoSmithKline Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.4.5 GlaxoSmithKline Recent Development 7.5 Hoffmann 7.5.1 Hoffmann Company Details 7.5.2 Hoffmann Business Overview 7.5.3 Hoffmann Hepatitis B Virus (HBV) Introduction 7.5.4 Hoffmann Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.5.5 Hoffmann Recent Development 7.6 La Roche 7.6.1 La Roche Company Details 7.6.2 La Roche Business Overview 7.6.3 La Roche Hepatitis B Virus (HBV) Introduction 7.6.4 La Roche Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.6.5 La Roche Recent Development 7.7 Bristol-Myers Squibb 7.7.1 Bristol-Myers Squibb Company Details 7.7.2 Bristol-Myers Squibb Business Overview 7.7.3 Bristol-Myers Squibb Hepatitis B Virus (HBV) Introduction 7.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Virus (HBV) Business (2017-2022) 7.7.5 Bristol-Myers Squibb Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Hepatitis B Virus (HBV) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Hepatitis B Virus (HBV) Market Trends Table 3. Hepatitis B Virus (HBV) Market Drivers Table 4. Hepatitis B Virus (HBV) Market Challenges Table 5. Hepatitis B Virus (HBV) Market Restraints Table 6. Global Hepatitis B Virus (HBV) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Hepatitis B Virus (HBV) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Hepatitis B Virus (HBV) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Hepatitis B Virus (HBV) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Hepatitis B Virus (HBV) Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Hepatitis B Virus (HBV) Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Hepatitis B Virus (HBV) Revenue Share by Player, 2017-2022 Table 13. Global Hepatitis B Virus (HBV) Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Hepatitis B Virus (HBV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Virus (HBV) as of 2021) Table 15. Top Players of Hepatitis B Virus (HBV) in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Hepatitis B Virus (HBV) Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Hepatitis B Virus (HBV) Players in United States Market, Ranking by Revenue (2021) Table 20. United States Hepatitis B Virus (HBV) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Hepatitis B Virus (HBV) Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Hepatitis B Virus (HBV) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Hepatitis B Virus (HBV) Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Hepatitis B Virus (HBV) Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Hepatitis B Virus (HBV) Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Hepatitis B Virus (HBV) Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Hepatitis B Virus (HBV) Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Hepatitis B Virus (HBV) Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Hepatitis B Virus (HBV) Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Merck Company Details Table 31. Merck Business Overview Table 32. Merck Hepatitis B Virus (HBV) Product Table 33. Merck Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 34. Merck Recent Development Table 35. Gilead Sciences Company Details Table 36. Gilead Sciences Business Overview Table 37. Gilead Sciences Hepatitis B Virus (HBV) Product Table 38. Gilead Sciences Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 39. Gilead Sciences Recent Development Table 40. Novartis Company Details Table 41. Novartis Business Overview Table 42. Novartis Hepatitis B Virus (HBV) Product Table 43. Novartis Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 44. Novartis Recent Development Table 45. GlaxoSmithKline Company Details Table 46. GlaxoSmithKline Business Overview Table 47. GlaxoSmithKline Hepatitis B Virus (HBV) Product Table 48. GlaxoSmithKline Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 49. GlaxoSmithKline Recent Development Table 50. Hoffmann Company Details Table 51. Hoffmann Business Overview Table 52. Hoffmann Hepatitis B Virus (HBV) Product Table 53. Hoffmann Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 54. Hoffmann Recent Development Table 55. La Roche Company Details Table 56. La Roche Business Overview Table 57. La Roche Hepatitis B Virus (HBV) Product Table 58. La Roche Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 59. La Roche Recent Development Table 60. Bristol-Myers Squibb Company Details Table 61. Bristol-Myers Squibb Business Overview Table 62. Bristol-Myers Squibb Hepatitis B Virus (HBV) Product Table 63. Bristol-Myers Squibb Revenue in Hepatitis B Virus (HBV) Business (2017-2022) & (US$ Million) Table 64. Bristol-Myers Squibb Recent Development Table 65. Research Programs/Design for This Report Table 66. Key Data Information from Secondary Sources Table 67. Key Data Information from Primary Sources List of Figures Figure 1. Hepatitis B Virus (HBV) Product Picture Figure 2. Global Hepatitis B Virus (HBV) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Hepatitis B Virus (HBV) Market Size 2017-2028 (US$ Million) Figure 4. United States Hepatitis B Virus (HBV) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Hepatitis B Virus (HBV) Market Size 2017-2028 (US$ Million) Figure 6. United States Hepatitis B Virus (HBV) Market Share in Global 2017-2028 Figure 7. Hepatitis B Virus (HBV) Report Years Considered Figure 8. Product Picture of Therapeutics Figure 9. Product Picture of Vaccine Figure 10. Global Hepatitis B Virus (HBV) Market Share by Type in 2022 & 2028 Figure 11. Global Hepatitis B Virus (HBV) Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Hepatitis B Virus (HBV) Market Share by Type (2017-2028) Figure 13. United States Hepatitis B Virus (HBV) Market Share by Type in 2022 & 2028 Figure 14. United States Hepatitis B Virus (HBV) Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Hepatitis B Virus (HBV) Market Share by Type (2017-2028) Figure 16. Product Picture of Hospitals Figure 17. Product Picture of Ambulatory Surgical Centers Figure 18. Product Picture of Diagnostic Centers Figure 19. Global Hepatitis B Virus (HBV) Market Share by Application in 2022 & 2028 Figure 20. Global Hepatitis B Virus (HBV) Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Hepatitis B Virus (HBV) Market Share by Application (2017-2028) Figure 22. United States Hepatitis B Virus (HBV) Market Share by Application in 2022 & 2028 Figure 23. United States Hepatitis B Virus (HBV) Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Hepatitis B Virus (HBV) Market Share by Application (2017-2028) Figure 25. North America Hepatitis B Virus (HBV) Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Hepatitis B Virus (HBV) Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Hepatitis B Virus (HBV) Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Hepatitis B Virus (HBV) Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Hepatitis B Virus (HBV) Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Hepatitis B Virus (HBV) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Merck Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 54. Gilead Sciences Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 55. Novartis Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 56. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 57. Hoffmann Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 58. La Roche Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Virus (HBV) Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed
Merck Gilead Sciences Novartis GlaxoSmithKline Hoffmann La Roche Bristol-Myers Squibb
  • PRICE
  • $4350
    $8700
    $5075
    Buy Now

Our Clients